Savulescu-Fiedler I, Dorobantu-Lungu L, Dragosloveanu S, Benea S, Dragosloveanu C, Caruntu A
Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996836
PMC: 11853762.
DOI: 10.3390/cimb47020115.
Zhao Y, Huang Y, Cao Y, Yang J
Biomolecules. 2024; 14(10).
PMID: 39456137
PMC: 11505625.
DOI: 10.3390/biom14101204.
Kim J, Choi C
Curr Issues Mol Biol. 2024; 46(10):11646-11664.
PMID: 39451571
PMC: 11505999.
DOI: 10.3390/cimb46100691.
Tian Z, Zhang Y, Xu J, Yang Q, Hu D, Feng J
Front Aging Neurosci. 2024; 16:1451655.
PMID: 39364348
PMC: 11447156.
DOI: 10.3389/fnagi.2024.1451655.
Gathings A, Zaman V, Banik N, Haque A
Biomedicines. 2024; 12(5).
PMID: 38791036
PMC: 11117523.
DOI: 10.3390/biomedicines12051074.
New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases.
Scarian E, Viola C, Dragoni F, Di Gerlando R, Rizzo B, Diamanti L
Int J Mol Sci. 2024; 25(5).
PMID: 38473944
PMC: 10931808.
DOI: 10.3390/ijms25052698.
Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson's disease.
Pons-Espinal M, Blasco-Agell L, Fernandez-Carasa I, Andres-Benito P, di Domenico A, Richaud-Patin Y
JCI Insight. 2024; 9(3).
PMID: 38329129
PMC: 10967472.
DOI: 10.1172/jci.insight.163359.
Neuroprotective Effects of Aldehyde-Reducing Composition in an LPS-Induced Neuroinflammation Model of Parkinson's Disease.
Kang S, Noh Y, Oh S, Yoon H, Im S, Kwon H
Molecules. 2023; 28(24).
PMID: 38138478
PMC: 10745824.
DOI: 10.3390/molecules28247988.
A 3D In Vitro Cortical Tissue Model Based on Dense Collagen to Study the Effects of Gamma Radiation on Neuronal Function.
Lojek N, Williams V, Rogers A, Sajo E, Black B, Ghezzi C
Adv Healthc Mater. 2023; 13(3):e2301123.
PMID: 37921265
PMC: 11468710.
DOI: 10.1002/adhm.202301123.
Expanding causal genes for Parkinson's disease via multi-omics analysis.
Gu X, Su W, Dou M, Jiang Z, Duan Q, Yin K
NPJ Parkinsons Dis. 2023; 9(1):146.
PMID: 37865667
PMC: 10590374.
DOI: 10.1038/s41531-023-00591-0.
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson's Disease.
Jurcau A, Andronie-Cioara F, Nistor-Cseppento D, Pascalau N, Rus M, Vasca E
Int J Mol Sci. 2023; 24(19).
PMID: 37834030
PMC: 10573049.
DOI: 10.3390/ijms241914582.
Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment.
Eker F, Bolat E, Pekdemir B, Duman H, Karav S
Front Aging Neurosci. 2023; 15:1204149.
PMID: 37731953
PMC: 10508234.
DOI: 10.3389/fnagi.2023.1204149.
Parkinson's Disease: A Tale of Many Players.
Pauwels E, Boer G
Med Princ Pract. 2023; 32(3):155-165.
PMID: 37285828
PMC: 10601631.
DOI: 10.1159/000531422.
Reactive astrocytes targeting with oral vitamin A: Efficient neuronal regeneration for Parkinson's disease treatment and reversal of associated liver fibrosis.
El-Mezayen N, Attia M, Shafik M, Gowied H, Abdel-Aal H, Abdel-Hady S
CNS Neurosci Ther. 2023; 29(8):2111-2128.
PMID: 36949616
PMC: 10352881.
DOI: 10.1111/cns.14179.
LRRK2 decreases microglial actin dynamics by filamentous actin depolymerization and Rac1 inhibition.
Kim B, Suh Y, Joe E
Anim Cells Syst (Seoul). 2023; 26(6):380-387.
PMID: 36605588
PMC: 9809388.
DOI: 10.1080/19768354.2022.2158219.
Managing Intractable Symptoms of Parkinson's Disease: A Nonsurgical Approach Employing Infralow Frequency Neuromodulation.
Legarda S, Michas-Martin P, McDermott D
Front Hum Neurosci. 2022; 16:894781.
PMID: 35880105
PMC: 9308006.
DOI: 10.3389/fnhum.2022.894781.
An apoptosis inhibitor suppresses microglial and astrocytic activation after cardiac ischemia/reperfusion injury.
Liao S, Luo Y, Chunchai T, Singhanat K, Arunsak B, Benjanuwattra J
Inflamm Res. 2022; 71(7-8):861-872.
PMID: 35655102
DOI: 10.1007/s00011-022-01590-2.
Autophagy modulation in multiple sclerosis and experimental autoimmune encephalomyelitis.
Shen D, Liu K, Wang H, Wang H
Clin Exp Immunol. 2022; 209(2):140-150.
PMID: 35641229
PMC: 9390842.
DOI: 10.1093/cei/uxac017.
Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders.
Mitra S, Banik A, Saurabh S, Maulik M, Khatri S
J Neurosci. 2022; 42(10):1888-1907.
PMID: 35027409
PMC: 8916763.
DOI: 10.1523/JNEUROSCI.0998-21.2022.
Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson's Disease: a Systematic Review.
Santos M, Schimith L, Andre-Miral C, Muccillo-Baisch A, Arbo B, Hort M
Neurotox Res. 2022; 40(1):319-345.
PMID: 35013904
DOI: 10.1007/s12640-021-00450-x.